CS191212B2 - Method of producing lysergamides - Google Patents

Method of producing lysergamides

Info

Publication number
CS191212B2
CS191212B2 CS73816A CS81673A CS191212B2 CS 191212 B2 CS191212 B2 CS 191212B2 CS 73816 A CS73816 A CS 73816A CS 81673 A CS81673 A CS 81673A CS 191212 B2 CS191212 B2 CS 191212B2
Authority
CS
Czechoslovakia
Prior art keywords
lysergamides
producing
producing lysergamides
Prior art date
Application number
CS73816A
Other languages
Czech (cs)
English (en)
Inventor
Erzsebet Mago
Tibor Balogh
Emilia Uskert
Jozsef Borsi
Lajos Wolf
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from HUGO001187 external-priority patent/HU163546B/hu
Priority claimed from HUGO001186 external-priority patent/HU164051B/hu
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of CS191212B2 publication Critical patent/CS191212B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • C07D457/06—Lysergic acid amides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • C07D457/06—Lysergic acid amides
    • C07D457/08—Lysergic acid amides in which the amide nitrogen is a member of a heterocyclic ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CS73816A 1972-02-04 1973-02-02 Method of producing lysergamides CS191212B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HUGO001187 HU163546B (sv) 1972-02-04 1972-02-04
HUGO001186 HU164051B (sv) 1972-02-04 1972-02-04

Publications (1)

Publication Number Publication Date
CS191212B2 true CS191212B2 (en) 1979-06-29

Family

ID=26318474

Family Applications (1)

Application Number Title Priority Date Filing Date
CS73816A CS191212B2 (en) 1972-02-04 1973-02-02 Method of producing lysergamides

Country Status (20)

Country Link
JP (1) JPS5221516B2 (sv)
AU (1) AU475943B2 (sv)
BE (1) BE794888A (sv)
BG (1) BG22832A3 (sv)
CA (1) CA994342A (sv)
CH (1) CH589079A5 (sv)
CS (1) CS191212B2 (sv)
DD (1) DD104299A5 (sv)
DE (1) DE2305514A1 (sv)
DK (1) DK141531B (sv)
EG (1) EG10823A (sv)
FI (1) FI54118C (sv)
FR (1) FR2190440B1 (sv)
GB (1) GB1401155A (sv)
IL (1) IL41409A (sv)
NL (1) NL178256C (sv)
NO (1) NO133670C (sv)
SE (1) SE421424B (sv)
SU (1) SU468419A3 (sv)
YU (1) YU36730B (sv)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU169073B (sv) * 1974-05-28 1976-09-28
HU168914B (sv) * 1974-07-30 1976-08-28
HU172649B (hu) * 1975-04-24 1978-11-28 Gyogyszerkutato Intezet Sposob poluchenija novykh biologicheski aktivnykh lizergamidov
DE2802023A1 (de) * 1977-01-28 1978-08-03 Sandoz Ag Neue ergotderivate, ihre herstellung und verwendung
JPH0438472U (sv) * 1990-07-31 1992-03-31
IT1260156B (it) * 1992-08-03 1996-03-28 Fidia Spa Derivati dell'acido neuraminico
CN103827113A (zh) * 2011-06-23 2014-05-28 Map药物公司 新型氟麦角碱类似物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH475252A (de) * 1966-02-08 1969-07-15 Sandoz Ag Verfahren zur Herstellung neuer Lysergsäure-Derivate
AT291446B (de) * 1968-11-22 1971-07-12 Richter Gedeon Vegyeszet Verfahren zur Herstellung von neuen Apovincaminsäureamiden

Also Published As

Publication number Publication date
IL41409A (en) 1977-04-29
DE2305514A1 (de) 1973-08-16
FI54118B (fi) 1978-06-30
DK141531C (sv) 1980-10-06
YU26673A (en) 1982-02-25
NO133670B (sv) 1976-03-01
CH589079A5 (sv) 1977-06-30
JPS4886900A (sv) 1973-11-15
GB1401155A (en) 1975-07-16
JPS5221516B2 (sv) 1977-06-10
FI54118C (fi) 1978-10-10
YU36730B (en) 1984-08-31
NL7301369A (sv) 1973-08-07
NL178256B (nl) 1985-09-16
CA994342A (en) 1976-08-03
IL41409A0 (en) 1973-03-30
NO133670C (sv) 1976-06-09
AU5163373A (en) 1974-08-01
NL178256C (nl) 1986-02-17
AU475943B2 (en) 1976-09-09
BE794888A (fr) 1973-05-29
FR2190440B1 (sv) 1976-09-03
SE421424B (sv) 1981-12-21
DK141531B (da) 1980-04-14
SU468419A3 (ru) 1975-04-25
DD104299A5 (sv) 1974-03-05
BG22832A3 (sv) 1977-04-20
EG10823A (en) 1976-07-31
FR2190440A1 (sv) 1974-02-01

Similar Documents

Publication Publication Date Title
BG32717A3 (en) Method for obtaining of n- organo- n- phosphonomethylglicine- n- oxides
CS182793B2 (en) Method for production of substituted ce-pentanorprostaglandins
CS186710B2 (en) Method of producing bis-/4-hydroxyphenyl/alkanacids
CS183722B2 (en) Method for producing 3-hydroxycephalosporines
CS183686B2 (en) Method of producing 1-hydroxy-2-pyridones
CS183721B2 (en) Method of production of alfa-aminoacylcephalosporines
CA1008847A (en) Method of producing dl-methionyl-dl-methionine
CS182248B2 (en) Method of producing n-benzhydryl-n-p-hydroxy-benzylpiperazine
CS191212B2 (en) Method of producing lysergamides
CS192504B2 (en) Method of producing cyano-methyl-thioacetyl-cephalosporins
CS190393B2 (en) Method of producing antibiotic a-2315
BG24661A3 (en) Method of preparing d-1-11-deoxoprostaglandine-e
CS182781B2 (en) Method of producing 2,6-diaminodihydropyridines
CS183691B2 (en) Method for producing alkylsulphobenzylpenicillins
GB1414680A (en) Methods of forming die sections
CS188175B2 (en) Method of producing 15-substituted omega-nor-prostaglandins
CS181234B2 (en) Method of producing benzodioxol derivatives
CS181238B2 (en) Method of preparing 2-benzoyl-3-aminopyridines
CS183678B2 (en) Method of producing new alfa-/o-sulphobenzimido/lactames
IT1006116B (it) Metodo per produrre l serina
CS187377B2 (en) Method of producing novel cyclohexone derivatives
KR780000447B1 (en) Method of producing benzylamine
CS193022B2 (en) Method of producing derivatives of phosphonourea or phosphonothiourea
CS193019B2 (en) Method of producing 15alpha-methylene-4-estrene-17beta-ols
CS178903B2 (en) Method of producing urethans